CNC · Centene Corporation

Healthcare NYQ United States centene.com ↗
Val Gro Qua Mom Sta Cap P/S0.18 P/E Fwd P/E12.50 PEG0.77 52W –  RSI Target$71.78 (+8.1%) Beta1.11 Div
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Healthcare Plans Saint Louis, United States 61,100 employees
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 53 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral

Momentum Signals 11

▲ Bull Flag 2026-06-01 · $59.97
▲ MACD Bullish Crossover 2026-06-09 · $66.21
▲ Bull Flag 2026-07-01 · $65.76
▲ MACD Bullish Crossover 2026-07-02 · $67.86

No major reversal patterns in the last 4 months — showing momentum signals only.

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Oct 27, 2026
Beat Rate 88%
Consensus BUY
Analyst Upside +8.1%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
88% 7/8 quarters
Wall Street Consensus
BUY
9
11
1
BuyHoldSell
Price Target Range
$71.78 +8.1% upside
Low $56 High $85
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 11.42%Last 12 Months
Operating Margin 3.76%Last 12 Months
Return on Equity -20.36%Last 12 Months
Revenue Growth 4.60%Year over Year
Free Cash Flow 9.64BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 71.08Most Recent Quarter
Current Ratio 1.15Most Recent Quarter
Cash 27.06BMost Recent Quarter
Total Debt 16.10BMost Recent Quarter
Net Debt Most Recent Quarter
How CNC Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap32.81B
Enterprise Value21.95B
Trailing P/EN/A
Forward P/E12.50
PEG Ratio (5yr)0.77
Price/Sales (ttm)0.18
Price/Book (mrq)1.45
EV/Revenue0.12
EV/EBITDA4.77
Share Statistics
Avg Vol (3m)4.77M
Shares Outstanding494.00M
Float463.69M
% Held by Insiders0.39%
% Held by Institutions101.61%
Short Ratio3.26
Short % of Float3.11%
Profitability
Gross Margin11.42%
Operating Margin (ttm)3.76%
Profit Margin-2.83%
Return on Assets (ttm)2.48%
Return on Equity (ttm)-20.36%
Income Statement
Revenue (ttm)180.30B
Revenue Growth (yoy)4.60%
Gross Profit (ttm)20.58B
EBITDA4.61B
Net Income (ttm)-5.10B
Diluted EPS (ttm)-10.52
EPS Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)27.06B
Total Debt (mrq)16.10B
Debt / Equity (mrq)71.08
Current Ratio (mrq)1.15
Book Value / Share45.67
Operating CF (ttm)9.75B
Free Cash Flow (ttm)9.64B
Trading & Dividends
Beta (5Y)1.11
50-Day MA65.52
200-Day MA50.77
Fwd Dividend YieldN/A
Payout Ratio0.00%

No dividend history available for CNC.

Ownership Breakdown
Institutional 101.61% Insider 0.39%
Short Interest 3.11% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in CNC in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value